Erika Cavallone
Program Manager
Radiology
School of Medicine

Publications (3)

Top publication keywords:
Skin NeoplasmsRegistriesNeoplasm Recurrence, LocalCognitive DysfunctionRituximabLymphoma, T-CellRetreatmentBendamustine HydrochlorideNauseaLymphoma, T-Cell, PeripheralLymphoma, Non-HodgkinLymphoma, T-Cell, CutaneousAntineoplastic Combined Chemotherapy ProtocolsDepsipeptidesNeuropsychological Tests

• Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.
  Alzheimer's research & therapy 2025 Kang JM, Manjavong M, Jin C, Diaz A, Ashford MT, Eichenbaum J, Thorp E, Wragg E, Zavitz KH, Cormack F, Aaronson A, Mackin RS, Tank R, Landavazo B, Cavallone E, Truran D, Farias ST, Weiner MW, Nosheny …
• Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.
  Clinical lymphoma, myeloma & leukemia 2020 Kambhampati S, Fakhri B, Ai WZ, Kaplan LD, Tuscano JM, Wieduwilt MJ, Sudhindra A, Cavallone E, Reiner J, Aoun C, Castillo M, Martinelli M, Ta T, Le D, Padilla M, Crawford E, Andreadis CB
• Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Vu K, Wu CH, Yang CY, Zhan A, Cavallone E, Berry W, Heeter P, Pincus L, Wieduwilt MJ, William BM, Andreadis C, Kaplan LK, McCormick F, Porcu P, Brammer JE, Ai WZ